Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSET low-dose theophylline in severe COPD
2008-005210-44Phase 4Active
- Sponsor
- Organisation name was not entered
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Low-dose theophylline + ICS + LABA with Placebo + ICS + LABA (2 arms). Primary endpoint: Exacerbation rate. Started Dec 2008; status: active.
02
Drugs
theophylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-005210-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005210-44.